Knights of Columbus Asset Advisors’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Knights of Columbus Asset Advisors’s Portfolio SURF Stock Details SURF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-157,769	Closed	-$137K	–	398
2023 Q2	$137K	Hold	157,769	–	–	0.01%	331
2023 Q1	$110K	Sell	157,769 -125,184	-44%	-$101K	0.01%	325
2022 Q4	$232K	Sell	282,953 -321	-0.1%	-$316	0.02%	286
2022 Q3	$295K	Buy	283,274 +30,598	+12%	+$48.9K	0.03%	262
2022 Q2	$414K	Buy	252,676 +2,000	+0.8%	+$4.15K	0.04%	254
2022 Q1	$737K	Buy	250,676 +134,104	+115%	+$470K	0.06%	237
2021 Q4	$557K	Buy	116,572 +1,978	+2%	+$12.8K	0.05%	248
2021 Q3	$867K	Buy	114,594 +1,000	+0.9%	+$6.4K	0.08%	231
2021 Q2	$847K	Buy	113,594 +403	+0.4%	+$3.11K	0.08%	229
2021 Q1	$883K	Buy	+113,191	New	+$1.13M	0.09%	249

Knights of Columbus Asset Advisors's SURF Position: Q3 2023 in Review

Knights of Columbus Asset Advisors sold out of Surface Oncology, Inc. Common Stock (SURF) in Q3 2023, closing a stake of 157,769 shares — an estimated $137K sold.

Knights of Columbus Asset Advisors first reported a position in SURF in Q1 2021 and held it in 10 quarters. The position peaked at $883K in Q1 2021. 0 funds tracked by Wall St. Rank hold SURF as of Q3 2023.

Knights of Columbus Asset Advisors reported no remaining Surface Oncology, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Knights of Columbus Asset Advisors sold 157,769 Surface Oncology, Inc. Common Stock shares in Q3 2023, an estimated $137K.
Knights of Columbus Asset Advisors first reported a position in Surface Oncology, Inc. Common Stock in Q1 2021 and held it in 10 quarters.
Knights of Columbus Asset Advisors's Surface Oncology, Inc. Common Stock position peaked at $883K in Q1 2021.
0 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2023.

Based on Knights of Columbus Asset Advisors's 13F filing for Q3 2023, filed 1 Nov 2023.